Julia Gordon ESA-SRB-ANZOS 2025 in conjunction with ENSA

Abstracts this author is presenting:

• Improvement in metabolic dysfunction-associated steatotic liver disease in overweight and obese adults with incretin analogue pharmacotherapy — ESA Poster Listing: Clinical